CARIBOU BIOSCIENCES INC shareholders Q1 2022

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 105 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

CARIBOU BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$6,189,0007.17%
72 Investment Holdings, LLC 474,067$4,352,0004.76%
Velan Capital Investment Management LP 210,695$1,934,0001.80%
PFM Health Sciences, LP 4,370,545$40,122,0001.50%
Monashee Investment Management LLC 470,000$4,315,0001.25%
Avidity Partners Management LP 2,819,067$25,879,0000.54%
Rokos Capital Management LLP 849,334$7,899,0000.37%
Green Alpha Advisors, LLC 49,674$456,0000.31%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 181,304$1,664,0000.25%
Tekla Capital Management LLC 699,377$6,420,0000.22%
STANSBERRY ASSET MANAGEMENT, LLC 92,789$852,0000.14%
FARALLON CAPITAL MANAGEMENT LLC 2,657,052$24,392,0000.12%
Nelson Capital Management, LLC 64,858$595,0000.12%
Duquesne Family Office 271,430$2,492,0000.11%
MAVERICK CAPITAL LTD 652,542$5,990,0000.10%
Granahan Investment Management 286,672$2,632,0000.06%
SHELTON CAPITAL MANAGEMENT 182,000$1,671,0000.06%
Artal Group S.A. 105,347$967,0000.04%
Virtus ETF Advisers LLC 9,392$86,0000.04%
GSA CAPITAL PARTNERS LLP 25,021$230,0000.03%

This page lists CARIBOU BIOSCIENCES INC's shareholders in Q1 2022. To view CARIBOU BIOSCIENCES INC's shareholder history, click here.